Gemcitabine treatment of cancer cells eventually elevated splicing factor SRSF1, thus inducing an AS of the MAP kinase-interacting serine/threonine-protein kinase 2 (MNK2) gene towards its MNK2b variant. Here, NEK4 is linked to cancer.